PRE-CLINICAL CHARACTERIZATION OF CAVROTOLIMOD, A TLR9 AGONIST FOR THE TREATMENT OF CHRONIC HEPATITIS B

被引：0
|
作者：
Ramos, Hilario [1 ]
Deval, Jerome [1 ]
Stanton, Jenny [1 ]
Shulman, Nancy [1 ]
Javanbakht, Hassan [1 ]
机构：
[1] Bluejay Therapeut, San Mateo, CA USA
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
459
引用
收藏
页码：S335 / S335
页数：1
相关论文
共 50 条
  • [1] Treatment of hepatitis C by an oligodeoxynucleotide that stimulates the TLR9
    Boulestin, A.
    VIROLOGIE, 2008, 12 (01) : 73 - 74
  • [2] Tolamba™ -: TLR9 receptor agonist treatment of allergic rhinitis
    Wang, Y.
    DRUGS OF THE FUTURE, 2007, 32 (06) : 497 - 500
  • [3] Pre-Clinical and Clinical Evaluation of Topical TLR7 Agonist Imiquimod for the Treatment of Breast Cancer
    Adams, Sylvia
    Dewan, Zahidunnabi
    Meng, Tze-Chiang
    Babb, James
    Bhardwaj, Nina
    Formenti, Silvia
    Demaria, Sandra
    JOURNAL OF IMMUNOTHERAPY, 2010, 33 (08) : 889 - 890
  • [4] Therapeutic vaccination in chronic hepatitis B: pre-clinical studies in the woodchuck
    Roggendorf, M.
    Lu, M.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S6 - S6
  • [5] TLR9 expression and functional impairment of plasmacytoid dendritic cells in patients with chronic hepatitis B
    Sheng, Huaicheng
    Xie, Qing
    An, BaoYan
    Jia, Ni Na
    Wang, Hui
    Zhou, Xia Qiu
    Guo, Qing
    Yu, Hong
    HEPATOLOGY, 2006, 44 (04) : 537A - 538A
  • [6] Immunophenotyping profile of CPG 10101, a new TLR9 agonist antiviral for hepatitis C
    McHutchinson, JG
    Bacon, BR
    Gordon, SC
    Lawitz, E
    Shiffman, M
    Afdhal, NH
    Jacobson, IM
    Muir, A
    Efler, SM
    Vicari, A
    Myette, K
    Ahluwalia, N
    Murzenok, PP
    Lipford, G
    Schmalbach, TK
    Krieg, AM
    Davis, HL
    HEPATOLOGY, 2005, 42 (04) : 539A - 540A
  • [7] TLR9: an important molecule in the fight against hepatitis B virus
    Shahrakyvahed, Aziz
    Sanchooli, Javad
    Sanadgol, Nima
    Arababadi, Mohammad Kazemi
    Kennedy, Derek
    POSTGRADUATE MEDICAL JOURNAL, 2014, 90 (1065) : 396 - 401
  • [8] TLR9 expression and functional impairment of plasmacytoid dendritic cells in patients with chronic hepatitis B infection
    Jia, N. N.
    Xie, Q.
    An, B. Y.
    Shen, H. C.
    Gui, H. L.
    Lin, L. Y.
    Wang, H.
    Zhou, X. Q.
    Yu, H.
    Guo, Q.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S162 - S162
  • [9] A first-in-human phase 1 study of cavrotolimod, a TLR9 agonist spherical nucleic acid, in healthy participants: Evidence of immune activation
    Daniel, Weston L. L.
    Lorch, Ulrike
    Mix, Scott
    Bexon, Alice S. S.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [10] Cobitolimod Toll-like receptor 9 (TLR9) agonist Treatment of ulcerative colitis
    Cole, P.
    DRUGS OF THE FUTURE, 2017, 42 (06) : 323 - 326
12345